CMMB: Chemomab Therapeutics Ltd - American Depositary Shares

CMMB新闻

• 19:02 Chemomab Therapeutics Ltd. (CMMB) Chemomab Therapeutics Ltd., - M&A Call - Slideshow (NASDAQ:CMMB) 2026-07-09
• 16:32 Chemomab Therapeutics Ltd. (CMMB) M&A Call Prepared Remarks Transcript
• 13:23 Chemomab’s nebokitug shows disease-modifying potential in PSC trial
• 13:05 Chemomab reports positive 48-week data for PSC drug nebokitug
• 14:27 ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition
• 14:00 Best Momentum Stocks to Buy for Oct. 23
• 11:05 New Strong Buy Stocks for Oct. 23: MQ, GES and More
• 14:18 SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study
• 13:34 Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis
• 13:30 NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients
• 15:52 ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up
• 15:44 NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs
• 15:14 Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
• 15:35 CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer
• 15:31 RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy
• 15:24 TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals
• 17:06 Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain
• 14:15 TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder
• 16:21 CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza
• 14:27 OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data
• 15:18 KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure
• 15:15 AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study
• 15:56 MRK Expands Tulisokibart Program in Three New Inflammatory Diseases